Table 2

Best-corrected visual acuity (ETDRS) after intravitreal injection in the IVB and IVB/IVF groups

Time pointTotalGroupDifference95%CIP values
Month 3
Change (baseline—3)
 ≥15 ETDRS letters13(31.0%)4(20.0%)9(40.9%)−20.9−‡
Month 6
Change (baseline—6)
 ≥15 ETDRS letters14(33.3%)2(10.0%)12(54.5%)−44.5−70.7−18.40.006‡
  • *Based on t-test.

  • †Adjusted for the baseline, based on analysis of covariance.

  • ‡Based on logistic regression.

  • §Based on linear mixed model, multiple comparison considered by Bonferroni method.

  • IVB, intravitreal injection of bevacizumab; IVB/IVF, intravitreal injection of both bevacizumab and fasudil.